An Overview of Molecular Abnormalities. A 1993 Perspective. Leading to Thyroid Carcinogenesis: ROBERT F. GAGEL ABSTRACT
|
|
- Edwin Miller
- 5 years ago
- Views:
Transcription
1 An Overview of Molecular Abnormalities Leading to Thyroid Carcinogenesis: A 1993 Perspective ROBERT F. GAGEL University of Texas, M.D. Anderson Cancer Center, Houston, Texas, USA Key Words. Medullary thyroid carcinoma Papillaty follicular thyroid carcinoma. Oncogene. Mutation ABSTRACT This discussion reviews molecular abnormalities in thyroid carcinoma and points out areas where these molecular defects might be applicable to thyroid carcinogenesis induced by radiation exposure. Both medullary and papillary follicular thyroid carcinoma are discussed. The multiple endocrine neoplasia type 2 gene on chromosome 10 is one of the genes responsible for medullary thyroid carcinoma. Genes thought to be involved in papillary and follicular thyroid carcinoma include the gsp, ret, trk, ras, met, and p53 oncogenes. Research is continuing to: A) find new genes whose regulation and/or expression may be responsible for these disorders; B) determine the mechanisms by which gene mutations can lead to thyroid carcinogenesis, and C) devise methods to prevent or counter the effects of these mutational events. Stern Cells 1997;15(suppl2):7-13 INTRODUCTION Our understanding of molecular abnormalities in both medullary and differentiated thyroid carcinoma is limited, as the field began to develop in This review of thyroid carcinogenesis will focus on reports implicating the role of gene rearrangements in the proto-oncogenes in the development of benign and malignant thyroid tumors. Our attention has been focused on the potential effects of the nuclear accident at Chernobyl, and most recently by reports that in regions within Belarus surrounding or downstream from the Chernobyl site, there has been a marked increase in the incidence of thyroid carcinoma [ 1, 21. While the report of Kuzakov et al. [I] is not well controlled and while it is unclear at this time whether the actual incidence (which was high in 1991) is a true incidence of thyroid cancer or whether it may reflect ascertainment bias; it points out clearly that an increased incidence of differentiated thyroid carcinoma (predominately papillary thyroid carcinoma) is evident in children who were in the region of Chernobyl. An interesting and inexplicable observation is the finding of a very high incidence of thyroid tumors in the Gomel region of the Republic of Belarus. Thyroid carcinoma can be subcategorized into two major types. The first type results from a transformation process of the calcitonin-producing cell (C-cell), [ I] or the perifollicular cell, which causes medullary thyroid carcinoma. The second type is derived from the follicular epithelium and encompasses predominately the follicular, papillary and anaplastic carcinomas, and a variant of the latter known as Radiation Injury and the Chernobyl Catastrophe. STEM CELLS 1997;15(suppl2): AlphaMed Press. All rights reserved.
2 8 Molecular Abnormalities in Thyroid Carcinoma Hurthle cell carcinoma. The close histologic relationship between the C-cell and the follicular cell has been a point of interest to both investigators interested in differentiated or papillary follicular thyroid carcinoma, as well as to those individuals who are interested in neoplasms of the C-cell. MEDULLARY THYROID CARCINOMA Much progress has been made towards mapping the multiple endocrine neoplasia type 2 (MEN2), or familial medullary thyroid carcinoma gene. In 1987, two groups reported linkage to a centromeric chromosome 10 locus [3, 41. There has been a considerable amount of work since that time in mapping the genetic locus with the acquisition of a large number of polymorphic DNA sequences within the region. Efforts now continue to develop yeast artificial chromosome libraries that contain DNA from this region. To date, the predisposing gene has not been cloned, although additional mutations have been identified. As the molecular basis is determined for both medullary thyroid carcinoma and differentiated carcinoma, a pattern is emerging suggesting that it is not a single molecular defect that leads to transformation of either cell type. There is now strong evidence that mutations in several tumor suppressor genes located on chromosomes lp and 22q are involved in the genesis of medullary thyroid carcinoma. PAPILLARY FOLLICULAR THYROID CARCINOMA At present there are six candidate genes (outlined below), for which a reasonable amount of evidence has accumulated to indicate involvement in the molecular defects of differentiated thyroid carcinoma [5]. Figure 1 shows a schematic diagram demonstrating the follicular cell adjacent to a follicle. The thyroid follicular cell normally synthesizes thyroglobulin and extrudes this protein into the follicle where it is stored; thyroglobulin is then taken back into the thyroid follicular cell and degraded when thyroid hormone is needed. Regulation of the thyroid follicular cell is, to a large extent, dependent upon a pituitary hormone called thyroid-stimulating hormone (TSH). The receptor for TSH, which has been cloned, is a transmembrane protein that is linked to at least two different transduction systems. The first pathway, considered to be the most important, is linked through the stimulatory subunit of a G protein that facilitates the production of cyclic AMP and the activation of protein kinase A, and sets in motion a series of phosphorylation events. There is a second pathway that in recent years has taken on greater importance, and that is the linkage of the same TSH receptor to a phospholipase C, which leads to the activation of protein kinase C and the production of inositol triphosphates. THYROID FOLLICULAR CELL Figure 1. Diagram of a thyroid follicular cell showing the several pathways implicated in the development of thyroid follicular neoplasms. The primary molecular defect in all examples except the p53 tumor suppressor gene is a membrane associated receptor or linker protein. The abbreviations,for these oncogenes ure discussed in the text.
3 Gagel 9 gsp A hot thyroid nodule is diagnosed by thyroidologists when the radioactive iodine scan of the thyroid gland shows an area of increased uptake in one region with relative suppression of uptake in the surrounding area and in the contralateral lobe. Based on studies performed by Bourne et al. showing abnormalities of the GS subunit in pituitary tumors, the possibility arises that abnormalities in the G-protein might be involved in the development of toxic adenomas, or hot nodules. In fact, such abnormalities have been found in a significant percentage of tumors in which hot nodules have been documented [6]. Table 1, adapted from a review by Wynford-Thomas [5], shows the characteristics of gsp (Ga subunit) mutations in thyroid tumors. Mutations in the alpha subunit of G protein have been found in both thyroid adenomas and carcinomas. Specific mutations have been identified in regions of the genes that are involved in activation of adenylate cyclase, and the mechanism of these mutations is believed to be an impairment of the GTPase activity of the protein. These mutations have been associated with increased adenylate cyclase activity in most tumors, again indicating that they are functional in a large percentage of tumors in which they have been found. ret and trk The first identification of molecular abnormalities in thyroid carcinoma came as a result of work performed by two groups of investigators [7-lo]. Takahashi and colleagues frst identified the c-ret proto-oncogene [9, lo]. An Italian collaborative group frst Table 1. Features of gsp (Ga subunit) mutations in thyroid tumorsa A Mutations are present in adenomas and carcinomas. A Mutations in codon? 201 or 227 result in continuous activation of adenylate cyclaye by iinpairing GTPase activity of the protein A Mutations are associated with increased adenylate cyclase activity in tumors *>Adapted from [5] demonstrated that there was activation of ret and trk oncogenes in papillary thyroid carcinoma [7,8]. These discoveries were first made by the use of a relatively simple but elegant assay for detecting transformation, depicted in Figure 2. High molecular weight DNA was extracted from either thyroid tumors or from normal blood cells from patients. DNA was then transfected into NIH 3T3 cells, a fibroblast-like cell line, using the calcium phosphate precipitation technique. After several weeks, subclones of rapidly proliferating transfectants were removed and then injected into nude mice that subsequently developed tumors. DNA derived from these tumors was used to develop a thyroid tumor library from which the c-ret and trk oncogenes were identified. (c. High molecular Transfection 1 0 weightdna prepared from tumor and normal blood cells \ \ n Figure 2. Transformation assay used to identify the c-ret and trk rearrangements found in papillary thyroid carcinoma. [ Identification of cloned DNA Analysis of tumor 4- DNA by Southern blotting
4 10 Molecular Abnormalities in Thyroid Carcinoma ret rearrangements, such as the chromosome 10 inversion shown in Figure 3, are found in 10%-50% of cases of papillary thyroid carcinoma. The low percentage of tumors which carries this rearrangement suggests that it evolves only in the later stages of transformation, or that it plays a role in only a small percentage of tumors. In fact, recent results suggest that ret is present in a high percentage of metastatic thyroid carcinomas. Thus, ret rearrangements may be more important in the evolution of carcinogenic states than in initiating cancer. The ret oncogene has also been linked to the predisposing locus for medullary thyroid carcinoma. What relationship there might be between papillary thyroid carcinoma and medullary thyroid carcinoma, and this abnormality, remains unknown. ras A second pathway within the thyroid follicular cell may mediate carcinogenesis via a cell surface growth factor receptor. It is well known that insulin growth factor 1, and perhaps also epidermal growth factor, are required for TSH action and normal growth and development. As indicated in Table 2, the rus 21 kda protein is found at the inner surface of the cell membrane and appears to perform a function similar to that of receptors for these growth factors (Le., degradation of GTP). This function is poorly understood but it is clear that mutations of either Harvey-, Kerstin- or N-rus are involved in the initiation of cell transformation [5]. Mutations have been found in all three rus genes in papillary and, to a lesser extent, follicular thyroid carcinoma (Table 3). Overall, the incidence of mutations of all three rus genes approximates 50% of thyroid carcinoma [5]. met Another tyrosine kinase, the H-met oncogene, is the receptor for a factor known as a hepatocyte growth factor. There is no evidence for rearrangement of the H-met gene, although it is overexpressed in papillary thyroid carcinoma. There has also I Papillary thyroid carcinoma oncogene s.'+x Chromosome 10 H4 PROMCYIER SEQUENCES INV(lO)(qll.zqZl) ret KlNASE SEQUENCES Figure 3. The most common rearrangement of the c-ret proto-oncogene involved in papillary thyroid carcinoma (PTC) is a chromosome 10 qll to 421 inversion in which the H4promoter sequence, ubiquitously expressed in the thyroid follicular cell, drives the expression of a truncated form of the c-ret proto-oncogene which contains the intracellular tyrosine kinase domain. I the inner surface of the cell membrane, and function to degrade A ras proteins alternate between GDP- and GTP-bound forms. A Mutation of codons 12/13 and 61 impair GTPase activity. A Effector sites are unknown. "Adapted from [5]. tions A Mutations occur in all three rus genes. A Mutations are found in about 50% of tumors, with the incidence of mutation lower in papillary than in follicular carcinoma. A The predominant mutation is substitution of glutamine for arginine at codon 61. A Mutations of K-ras may be more common in radiation-induced thyroid carcinoma. aadapted from [5].
5 Gagel 11 been an independent observation that parafollicular cells, or C-cells, may produce hepatocyte growth factors. This may provide one example in which there is interaction between two cell types within the thyroid gland milieu. P53 The p53 anti-oncogene, a tumor suppressor type of gene, has been implicated in the development of colon carcinoma and breast carcinoma. A mutation or loss of p53 has also been implicated in the transformation from a differentiated to an anaplastic thyroid carcinoma [I 11. The preceding sections describe the presently known molecular defects in papillary and follicular thyroid carcinoma. As one looks across the field of mutational events, it is evident that the incidence of mutations for any of these genes rarely exceeds 50%. Therefore, it is likely that other candidate genes remain undiscovered. STUDY OF THYROID CARCINOMA Table 4 outlines strategies for the identification of new molecular defects and attempts to integrate these into the subject of today s symposium: the increased incidence of thyroid carcinoma associated with radiation exposure. First, it will be important to study newly identified oncogenes. In fact, much of the progress that has already been made in this area has been merely a direct application of other Table 4. Strategies for identifieation work on other cancers. A second approach that we are planning to of new molecular defects pursue in our own cohort of patients with thyroid carcinoma is to A Study newly identified oncogenes attempt to identify the predisposing or causative genes in familial A Perform linkage analysis in farnilies with hereditary thyroid canpapillary thyroid carcinoma by using a linkage analysis and a can- cer didate gene approach. In addition, transgenic or knockout models A Make transgenic or gene knockout should be developed to assess the importance of a particular gene animal models. in carcinogenesis. Finally, groups of patients who have exposure to A Study populations known to be at environmental risks would also be interesting because one can greater risk for development of study those groups of patients from the beginning of exposure and thyroid carcinoma, wch as individuals exposed to irradiation. or try to understand the cascade of molecular events that evolves into living in iodine-deficient regions thyroid carcinoma. STRATEGIES FOR MOLECULAR ADDENDUM The period between 1993 and the publication of this review was a period of intense activity in the field of thyroid carcinogenesis. Studies in mid-1993 led to the identification of mutations of the c-ret rearrangement plays in the development of papillary thyroid carcinoma. The c-ret proto-oncogene is a member of the tyrosine kinase receptor family (Fig. 4) which is normally expressed in the thyroidal C cell, but not in the thyroid follicular cell [14]. Two classes of c-ret mutations have been identified in MEN 2 and FMTC. Mutation of a cysteine to another amino acid in the extracellular cysteine-rich domain results in dimerization, autophosphorylation, and activation of the receptor [ 15-17]. A second class of mutations affects the intracellular tyrosine kinase domain and causes receptor activation without dimerization [ 15-17]. More recent studies have identified a second component of the Ret tyrosine kinase complex, a receptor for glial cell-derived neurotrophic factor (GDNF) [ 181. Current information suggests the GDNF binds to the GDNF receptor, a membrane-associated receptor, which complexes with the Ret tyrosine kinase receptor [19,20]. The GDNF signal is transmitted to the intracellular compartment by the Ret tyrosine kinase receptor [19, 201. Whether mutations of GDNF or its receptor will be identified in MEN 2 or FMTC is unclear at this time, although approximately 5%-7% of patients with MEN 2 or FMTC have no identifiable c-ret proto-oncogene mutations, making this a possibility.
6 ~~ ~ 12 Molecular Abnormalities in Thyroid Carcinoma extracellular domains trk receptor kinase tyrosine kinase domain I extracellular domains trk fusion kinase tyrosine kinase domain CO-OH ICO-OH A 7 glycosylation site... disulfide bond B 7 exons of tropomycin, L7a ribosomal Drotein or TPR Figures 4A and 4B. Schematic representation of the normal trk receptor (4A) and the efsect of the chromosomal rearrangement which leads to activation of trk tyrosine kinase activity as discussed in [5]. The Ret tyrosine kinase is not normally expressed in the thyroid follicular cell. Three rearrangements of c-ret, designated PTCl, PTC2, and PTC3 [21], have been identified and result in expression of Ret tyre sine kinase activity within the thyroid follicular cell. Targeted expression of PTCl in a transgenic mouse results in histologic features of papillary thyroid carcinoma (PTC) [22]. Mice with a high copy number of the transgene also develop hypothyroidism, suggesting a relationship between Ret expression and regulation iodide transport or thyroid hormone syntheses [22]. Further exploration of this model system may result in an understanding of the defects in iodide transport seen in papillary thyroid carcinoma. Finally, evidence has accumulated that the initial increase in pediatric papillary thyroid carcinoma observed in children exposed to radiation from the Chernobyl disaster is real. Furthermore, the PTC rearrangement (Fig. 3) has been identified in approximately 60% of these children, suggesting that radiation-induced recombination is a potent stimulus for generation of this rearrangement. These findings also provide additional evidence for a causative role for this rearrangement in the genesis of PTC. The pace of discovery in this field has been rapid, suggesting the molecular defects in thyroid carcinoma may be elucidated over the next decade. REFERENCES 1 Kazakov VS, Demidchik EP, Astakhova LN. Thyroid cancer after Chemobyl. Nature 1992;359:21. 2 Baverstock K, Egloff B, Pinchera A et al. Thyroid cancer after Chernobyl. Nature 1992;359: Simpson NE, Kidd KK, Goodfellow PJ et al. Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage. Nature 1987;328: Mathew CG, Chin KS, Easton DF et al. A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10. Nature 1987;328: Wynford-Thomas D. Molecular basis of epithelial tumorigenesis: the thyroid model. Clin Rev Oncogenesis 1993;4: Lyons J, Landis CA, Harsh G et a]. Two G protein oncogeneses in human endocrine tumors. Science 1990;249: Santoro M, Rosati R, Grieco M et al. The Pet proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas. Oncogene 199O;S:lS Lanzi C, Borrello MG, Bongarzone I et al. Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas. Oncogene 1992;7: Takahashi M, Buma Y, Iwamoto T et al. Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains. Oncogene I988;3: Takahashi M. Structure and expression of the ref transforming gene. IARC Sci Pub1 1988;92: Fagin JA, Matsuo K, Karmakar A et al. High prevalence of mutations of the ps3 gene in
7 Gagel poorly differentiated human thyroid carcinomas. J Clin Invest 1993;91: Mulligan LM, Kwok JBJ, Healey CS et al. Germline mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A (MEN 2A). Nature 1993;363: Donis-Keller H, Dou S, Chi D et al. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 1993;2: Takahashi M, Ritz J, Cooper GM. Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell 1Y85;42: Xing S, Smanik PA, Oglesbee MJ et al. Characterization of ref oncogenic activation in MEN 2 inherited cancer syndromes. Endocrinology 1996; 137: Asai N, Iwashita T, Matsuyama M et al. Mechanisms of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations. Mol Cell Biol 1995;15: Santoro M, Carlornagno F, Romano A et al. Activation of RET as a dominant transforming gene by germline mutations of MEN 2A and MEN 2B. Science 1995;267: Jing S, Wen D, Yu Y et al. GDNF-induced activation of the Ret protein tyrosine kinase is mediated by GDMFR-a, a novel receptor for GDNF. Cell 1YY6;85: Durbec P, Marcos-Gutierrez CV, Kilkenny C et al. GDNF signalling through the ret receptor tyrosine kinase. Nature 1996;381: Trupp M, Arenas E, Falnzilber M et al. Functional receptor for GDNF encoded by the c-ref protooncogene. Nature 1996;381: Bongarzone I, Butti MG, Coronelli S et al. Frequent activation of RET protooncogene by fusion with a new activating gene in papillary thyroid carcinomas. Cancer Res 1994;54: Jhiang SM, Sag& JE, Tong Q et al. Targeted expression of the ret/ptcl oncogene induces papillary thyroid carcinomas. Endocrinology 1996; 137:
Oncogenes/Growth Factors & Environment
Oncogenes/Growth Factors & Environment 8 th Postgraduate Course in Endocrine Surgery Crete, Greece September, 2006 Orlo H. Clark M.D. Thyroid Cancer Thyroid cancer is the 8 th most common and most rapidly
More informationThe c-ret pathway and. K. Homicsko, Lucerne
The c-ret pathway and biomarkers K. Homicsko, 2.11.12 Lucerne Origins 1. c-ret is a proto-oncogene on chromosome 10 (10q11.2) 2. «rearranged during transfection» 3. Synonyms: CDHF12, HSCR1, MEN2A, MEN2B,
More informationEvaluation and Management of Thyroid Nodules. Nick Vernetti, MD, FACE Palm Medical Group Las Vegas, Nevada
Evaluation and Management of Thyroid Nodules Nick Vernetti, MD, FACE Palm Medical Group Las Vegas, Nevada Disclosure Consulting Amgen Speaking Amgen Objectives Understand the significance of incidental
More informationCarcinoma midollare tiroideo familiare
12 AME Italian Meeting 6 Joint Meeting with AACE Carcinoma midollare tiroideo familiare Profilo genetico e stratificazione del rischio Maria Chiara Zatelli Sezione di Endocrinologia Dipartimento di Scienze
More informationRAS Genes. The ras superfamily of genes encodes small GTP binding proteins that are responsible for the regulation of many cellular processes.
۱ RAS Genes The ras superfamily of genes encodes small GTP binding proteins that are responsible for the regulation of many cellular processes. Oncogenic ras genes in human cells include H ras, N ras,
More informationWhat causes cancer? Physical factors (radiation, ionization) Chemical factors (carcinogens) Biological factors (virus, bacteria, parasite)
Oncogenes What causes cancer? Chemical factors (carcinogens) Physical factors (radiation, ionization) Biological factors (virus, bacteria, parasite) DNA Mutation or damage Oncogenes Tumor suppressor genes
More informationnumber Done by Corrected by Doctor Maha Shomaf
number 19 Done by Waseem Abo-Obeida Corrected by Abdullah Zreiqat Doctor Maha Shomaf Carcinogenesis: the molecular basis of cancer. Non-lethal genetic damage lies at the heart of carcinogenesis and leads
More informationTHYROID CANCER IN CHILDREN. Humberto Lugo-Vicente MD FACS FAAP Professor Pediatric Surgery UPR School of Medicine
THYROID CANCER IN CHILDREN Humberto Lugo-Vicente MD FACS FAAP Professor Pediatric Surgery UPR School of Medicine Thyroid nodules Rare Female predominance 4-fold as likely to be malignant Hx Radiation exposure?
More informationLecture 15. Signal Transduction Pathways - Introduction
Lecture 15 Signal Transduction Pathways - Introduction So far.. Regulation of mrna synthesis Regulation of rrna synthesis Regulation of trna & 5S rrna synthesis Regulation of gene expression by signals
More informationRossella Elisei. Department of Endocrinology, University Hospital, Pisa, Italy
Rossella Elisei Department of Endocrinology, University Hospital, Pisa, Italy THYROID CANCER IS RARE TUMOR AND REPRESENTS ONLY 3.8% OF ALL HUMAN TUMORS All human cancer Thyroid cancer MOST FREQUENT CANCER
More informationINDEX. Note: Page numbers of issue and article titles are in boldface type. cell carcinoma. ENDOCRINE SURGERY
ENDOCRINE SURGERY INDEX Note: Page numbers of issue and article titles are in boldface type. Adenylate cyclase, in signal transduction 425-426 Adrenal incidentalomas, 499-509 imaging of, 502-504 in patients
More informationoncogenes-and- tumour-suppressor-genes)
Special topics in tumor biochemistry oncogenes-and- tumour-suppressor-genes) Speaker: Prof. Jiunn-Jye Chuu E-Mail: jjchuu@mail.stust.edu.tw Genetic Basis of Cancer Cancer-causing mutations Disease of aging
More informationCalcitonin. 1
Calcitonin Medullary thyroid carcinoma (MTC) is characterized by a high concentration of serum calcitonin. Routine measurement of serum calcitonin concentration has been advocated for detection of MTC
More informationThyroid Nodules. Dr. HAKIMI, SpAK Dr. MELDA DELIANA, SpAK Dr. SISKA MAYASARI LUBIS, SpA
Thyroid Nodules ENDOCRINOLOGY DIVISION ENDOCRINOLOGY DIVISION Dr. HAKIMI, SpAK Dr. MELDA DELIANA, SpAK Dr. SISKA MAYASARI LUBIS, SpA Anatomical Considerations The Thyroid Nodule Congenital anomalies Thyroglossal
More informationInsulin Resistance. Biol 405 Molecular Medicine
Insulin Resistance Biol 405 Molecular Medicine Insulin resistance: a subnormal biological response to insulin. Defects of either insulin secretion or insulin action can cause diabetes mellitus. Insulin-dependent
More informationChapter 15: Signal transduction
Chapter 15: Signal transduction Know the terminology: Enzyme-linked receptor, G-protein linked receptor, nuclear hormone receptor, G-protein, adaptor protein, scaffolding protein, SH2 domain, MAPK, Ras,
More informationReceptor mediated Signal Transduction
Receptor mediated Signal Transduction G-protein-linked receptors adenylyl cyclase camp PKA Organization of receptor protein-tyrosine kinases From G.M. Cooper, The Cell. A molecular approach, 2004, third
More informationNEOPLASMS OF THE THYROID PATHOLOGY OF PARATHYROID GLANDS. BY: Shifaa Qa qa
NEOPLASMS OF THE THYROID PATHOLOGY OF PARATHYROID GLANDS BY: Shifaa Qa qa Neoplasmas of the thyroid thyroid nodules Neoplastic ---- benign, malignant Non neoplastic Solitary nodules ----- neoplastic Nodules
More informationCell Communication. Cell Communication. Communication between cells requires: ligand: the signaling molecule
Cell Communication Cell Communication Communication between cells requires: ligand: the signaling molecule receptor protein: the molecule to which the ligand binds (may be on the plasma membrane or within
More informationCell Communication. Cell Communication. Cell Communication. Cell Communication. Cell Communication. Chapter 9. Communication between cells requires:
Chapter 9 Communication between cells requires: ligand: the signaling molecule receptor protein: the molecule to which the receptor binds -may be on the plasma membrane or within the cell 2 There are four
More informationTransgenic Mice and Genetargeting
Transgenic Mice and Genetargeting mice In Biomedical Science Techniques of transgenic and gene-targeting mice are indispensable for analyses of in vivo functions of particular genes and roles of their
More information- RET/PTC rearrangement: 20% papillary thyroid cancer - RET: medullary thyroid cancer
Thyroid Cancer UpToDate: Introduction: Risk Factors: Biology: Symptoms: Diagnosis: 1. Lenvina is the first line therapy with powerful durable response and superior PFS in pts with RAI-refractory disease.
More informationModel Answer. M.Sc. Zoology (First Semester) Examination Paper LZT 103 (Endocrinology)
Model Answer M.Sc. Zoology (First Semester) Examination-2013 Paper LZT 103 (Endocrinology) Section A 1. (i) d (ii) b (iii) b (iv) c (v) c (vi) a (vii) c (viii) a (ix) d (x) b Section B Q.2 Answer Hormonal
More informationMultistep nature of cancer development. Cancer genes
Multistep nature of cancer development Phenotypic progression loss of control over cell growth/death (neoplasm) invasiveness (carcinoma) distal spread (metastatic tumor) Genetic progression multiple genetic
More informationPropagation of the Signal
OpenStax-CNX module: m44452 1 Propagation of the Signal OpenStax College This work is produced by OpenStax-CNX and licensed under the Creative Commons Attribution License 3.0 By the end of this section,
More informationAyman Mesleh & Leen Alnemrawi. Bayan Abusheikha. Faisal
24 Ayman Mesleh & Leen Alnemrawi Bayan Abusheikha Faisal We were talking last time about receptors for lipid soluble hormones.the general mechanism of receptors for lipid soluble hormones: 1. Receptors
More informationGenetics and Cancer Ch 20
Genetics and Cancer Ch 20 Cancer is genetic Hereditary cancers Predisposition genes Ex. some forms of colon cancer Sporadic cancers ~90% of cancers Descendants of cancerous cells all cancerous (clonal)
More informationTumor suppressor genes D R. S H O S S E I N I - A S L
Tumor suppressor genes 1 D R. S H O S S E I N I - A S L What is a Tumor Suppressor Gene? 2 A tumor suppressor gene is a type of cancer gene that is created by loss-of function mutations. In contrast to
More informationDr Rodney Itaki Lecturer Anatomical Pathology Discipline. University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology
Neoplasia Dr Rodney Itaki Lecturer Anatomical Pathology Discipline University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology General Considerations Overview: Neoplasia uncontrolled,
More informationCELL CYCLE REGULATION AND CANCER. Cellular Reproduction II
CELL CYCLE REGULATION AND CANCER Cellular Reproduction II THE CELL CYCLE Interphase G1- gap phase 1- cell grows and develops S- DNA synthesis phase- cell replicates each chromosome G2- gap phase 2- cell
More informationNEOPLASIA. 3. Which of the following tumour is benign a. Chondrosarcoma b. Osteochondroma c. Chondroblastoma d. Ewing s tumour e.
NEOPLASIA 1. malignant neoplasms a. are independent of hormonal influence b. are always composed of homogenous cell lines c. arise from differentiated cells by a process of anaplasia d. display abnormal
More informationLecture: CHAPTER 13 Signal Transduction Pathways
Lecture: 10 17 2016 CHAPTER 13 Signal Transduction Pathways Chapter 13 Outline Signal transduction cascades have many components in common: 1. Release of a primary message as a response to a physiological
More informationGenetic Testing in Medullary Thyroid Carcinoma
Genetic Testing in Medullary Thyroid Carcinoma Presenter-Dr Sunil Malla Bujar Barua Moderator- Prof Gaurav Agarwal 1 Genetic testing in MTC 24/4/2012 Background 1959 Hazard et al first described MTC 1961
More informationMolecular Cell Biology - Problem Drill 19: Cell Signaling Pathways and Gene Expression
Molecular Cell Biology - Problem Drill 19: Cell Signaling Pathways and Gene Expression Question No. 1 of 10 1. Which statement about cell signaling is correct? Question #1 (A) Cell signaling involves receiving
More informationG-Protein Signaling. Introduction to intracellular signaling. Dr. SARRAY Sameh, Ph.D
G-Protein Signaling Introduction to intracellular signaling Dr. SARRAY Sameh, Ph.D Cell signaling Cells communicate via extracellular signaling molecules (Hormones, growth factors and neurotransmitters
More informationGenetics of Cancer Lecture 32 Cancer II. Prof. Bevin Engelward, MIT Biological Engineering Department
Genetics of Cancer Lecture 32 Cancer II rof. Bevin Engelward, MIT Biological Engineering Department Why Cancer Matters New Cancer Cases in 1997 Cancer Deaths in 1997 Genetics of Cancer: Today: What types
More informationGoiter, Nodules and Tumors
Goiter, Nodules and Tumors Howard J. Sachs, MD www.12daysinmarch.com Thyroid Cancer Anaplastic Medullary Thyroid Cancer Anaplastic Medullary Thyroid Cancer Anaplastic Medullary Anaplastic Medullary MEN
More informationSignal Transduction Cascades
Signal Transduction Cascades Contents of this page: Kinases & phosphatases Protein Kinase A (camp-dependent protein kinase) G-protein signal cascade Structure of G-proteins Small GTP-binding proteins,
More informationLipids and Membranes
Lipids and Membranes Presented by Dr. Mohammad Saadeh The requirements for the Pharmaceutical Biochemistry I Philadelphia University Faculty of pharmacy Membrane transport D. Endocytosis and Exocytosis
More informationGENERAL CHARACTERISTICS OF THE ENDOCRINE SYSTEM FIGURE 17.1
GENERAL CHARACTERISTICS OF THE ENDOCRINE SYSTEM FIGURE 17.1 1. The endocrine system consists of glands that secrete chemical signals, called hormones, into the blood. In addition, other organs and cells
More informationGenome of Hepatitis B Virus. VIRAL ONCOGENE Dr. Yahwardiah Siregar, PhD Dr. Sry Suryani Widjaja, Mkes Biochemistry Department
Genome of Hepatitis B Virus VIRAL ONCOGENE Dr. Yahwardiah Siregar, PhD Dr. Sry Suryani Widjaja, Mkes Biochemistry Department Proto Oncogen and Oncogen Oncogen Proteins that possess the ability to cause
More informationEffects of Second Messengers
Effects of Second Messengers Inositol trisphosphate Diacylglycerol Opens Calcium Channels Binding to IP 3 -gated Channel Cooperative binding Activates Protein Kinase C is required Phosphorylation of many
More informationCell Biology Lecture 9 Notes Basic Principles of cell signaling and GPCR system
Cell Biology Lecture 9 Notes Basic Principles of cell signaling and GPCR system Basic Elements of cell signaling: Signal or signaling molecule (ligand, first messenger) o Small molecules (epinephrine,
More informationCell Signaling part 2
15 Cell Signaling part 2 Functions of Cell Surface Receptors Other cell surface receptors are directly linked to intracellular enzymes. The largest family of these is the receptor protein tyrosine kinases,
More informationCancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation
Cancer The fundamental defect is unregulated cell division. Properties of Cancerous Cells Altered growth and proliferation Loss of growth factor dependence Loss of contact inhibition Immortalization Alterated
More informationWhat you need to know about Thyroid Cancer
What you need to know about Thyroid Cancer This booklet has been designed to help you to learn more about your thyroid cancer. It covers the most important areas and answers some of the frequently asked
More informationHormones and Signal Transduction. Dr. Kevin Ahern
Dr. Kevin Ahern Signaling Outline Signaling Outline Background Signaling Outline Background Membranes Signaling Outline Background Membranes Hormones & Receptors Signaling Outline Background Membranes
More informationKEY CONCEPT QUESTIONS IN SIGNAL TRANSDUCTION
Signal Transduction - Part 2 Key Concepts - Receptor tyrosine kinases control cell metabolism and proliferation Growth factor signaling through Ras Mutated cell signaling genes in cancer cells are called
More informationChapt 15: Molecular Genetics of Cell Cycle and Cancer
Chapt 15: Molecular Genetics of Cell Cycle and Cancer Student Learning Outcomes: Describe the cell cycle: steps taken by a cell to duplicate itself = cell division; Interphase (G1, S and G2), Mitosis.
More informationTYROSINE KINASES ARE involved in the most essential
0163-769X/06/$20.00/0 Endocrine Reviews 27(5):535 560 Printed in U.S.A. Copyright 2006 by The Endocrine Society doi: 10.1210/er.2006-0017 RET as a Diagnostic and Therapeutic Target in Sporadic and Hereditary
More informationThyroid Nodules. Family Medicine Refresher Course Geeta Lal MD, FACS April 2, No financial disclosures
Thyroid Nodules Family Medicine Refresher Course Geeta Lal MD, FACS April 2, 2014 No financial disclosures Objectives Review epidemiology Work up of Thyroid nodules Indications for FNAB Evolving role of
More informationEnzyme-coupled Receptors. Cell-surface receptors 1. Ion-channel-coupled receptors 2. G-protein-coupled receptors 3. Enzyme-coupled receptors
Enzyme-coupled Receptors Cell-surface receptors 1. Ion-channel-coupled receptors 2. G-protein-coupled receptors 3. Enzyme-coupled receptors Cell-surface receptors allow a flow of ions across the plasma
More informationCancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation
Cancer The fundamental defect is unregulated cell division. Properties of Cancerous Cells Altered growth and proliferation Loss of growth factor dependence Loss of contact inhibition Immortalization Alterated
More informationActivation of cellular proto-oncogenes to oncogenes. How was active Ras identified?
Dominant Acting Oncogenes Eugene E. Marcantonio, M.D. Ph.D. Oncogenes are altered forms of normal cellular genes called proto-oncogenes that are involved in pathways regulating cell growth, differentiation,
More informationProtein kinases are enzymes that add a phosphate group to proteins according to the. ATP + protein OH > Protein OPO 3 + ADP
Protein kinase Protein kinases are enzymes that add a phosphate group to proteins according to the following equation: 2 ATP + protein OH > Protein OPO 3 + ADP ATP represents adenosine trisphosphate, ADP
More informationIntroduction. Cancer Biology. Tumor-suppressor genes. Proto-oncogenes. DNA stability genes. Mechanisms of carcinogenesis.
Cancer Biology Chapter 18 Eric J. Hall., Amato Giaccia, Radiobiology for the Radiologist Introduction Tissue homeostasis depends on the regulated cell division and self-elimination (programmed cell death)
More informationSignal Transduction: Information Metabolism. Chem 454: Regulatory Mechanisms in Biochemistry University of Wisconsin-Eau Claire
Signal Transduction: Information Metabolism Chem 454: Regulatory Mechanisms in Biochemistry University of Wisconsin-Eau Claire Introduction Information Metabolism How cells receive, process and respond
More informationVets 111/Biov 111 Cell Signalling-2. Secondary messengers the cyclic AMP intracellular signalling system
Vets 111/Biov 111 Cell Signalling-2 Secondary messengers the cyclic AMP intracellular signalling system The classical secondary messenger model of intracellular signalling A cell surface receptor binds
More informationCell Communication. Local and Long Distance Signaling
Cell Communication Cell to cell communication is essential for multicellular organisms Some universal mechanisms of cellular regulation providing more evidence for the evolutionary relatedness of all life
More informationThyroid cancers after the Chernobyl accident; lessons learnt, an update. Dillwyn Williams Cambridge
Thyroid cancers after the Chernobyl accident; lessons learnt, an update. Dillwyn Williams Cambridge What is the size of the increase in thyroid carcinomas and does it continue? What are the uncertainties
More informationThyroid Nodule. Disclosure. Learning Objectives P A P A P A 3/18/2014. Nothing to disclose.
Thyroid Nodule Evaluating the patient with a thyroid nodule and some management options. Miguel V. Valdez PA C Disclosure Nothing to disclose. Learning Objectives Examination of thyroid gland Options for
More informationCabozantinib for medullary thyroid cancer. February 2012
Cabozantinib for medullary thyroid cancer February 2012 This technology summary is based on information available at the time of research and a limited literature search. It is not intended to be a definitive
More informationCase year old female presented with asymmetric enlargement of the left lobe of the thyroid
Case 4 22 year old female presented with asymmetric enlargement of the left lobe of the thyroid gland. No information available relative to a prior fine needle aspiration biopsy. A left lobectomy was performed.
More informationChapter 11. Cell Communication
Chapter 11 Cell Communication Overview: The Cellular Internet Cell-to-cell communication Is absolutely essential for multicellular organisms Concept 11.1: External signals are converted into responses
More informationCase 4 Diagnosis 2/21/2011 TGB
Case 4 22 year old female presented with asymmetric enlargement of the left lobe of the thyroid gland. No information available relative to a prior fine needle aspiration biopsy. A left lobectomy was performed.
More informationLESSON 3.2 WORKBOOK. How do normal cells become cancer cells? Workbook Lesson 3.2
For a complete list of defined terms, see the Glossary. Transformation the process by which a cell acquires characteristics of a tumor cell. LESSON 3.2 WORKBOOK How do normal cells become cancer cells?
More informationIndex. Surg Oncol Clin N Am 15 (2006) Note: Page numbers of article titles are in boldface type.
Surg Oncol Clin N Am 15 (2006) 681 685 Index Note: Page numbers of article titles are in boldface type. A Ablative therapy, for liver metastases in patients with neuroendocrine tumors, 517 with radioiodine
More informationINTERACTION DRUG BODY
INTERACTION DRUG BODY What the drug does to the body What the body does to the drug Receptors - intracellular receptors - membrane receptors - Channel receptors - G protein-coupled receptors - Tyrosine-kinase
More informationManagement of Thyroid Nodules
Management of Thyroid Nodules 38 y/o female with solid 1.5 cm right Thyroid nodule. TSH=0.68 Vincent J. Reid, MD., FACS Thyroid Cancer Incidence & Mortality 1974 to 2004 Overall Women Men Mortality 1 Cancer
More informationTHYROID TUMOR DIAGNOSIS: MARKER OF THE MONTH CLUB
THYROID TUMOR DIAGNOSIS: MARKER OF THE MONTH CLUB CHARACTERISTIC OF THE IDEAL TUMOR MARKER Specific Sensitive Easy to perform Easy to interpret Adaptable to FNA Reasonable cost (CHEAP) THYROID TUMOR MARKERS
More informationCell Communication. Chapter 11. Biology. Eighth Edition Neil Campbell and Jane Reece. PowerPoint Lecture Presentations for
Chapter 11 Cell Communication PowerPoint Lecture Presentations for Biology Eighth Edition Neil Campbell and Jane Reece Lectures by Chris Romero, updated by Erin Barley with contributions from Joan Sharp
More informationRevision. camp pathway
االله الرحمن الرحيم بسم Revision camp pathway camp pathway Revision camp pathway Adenylate cyclase Adenylate Cyclase enzyme Adenylate cyclase catalyses the formation of camp from ATP. Stimulation or inhibition
More informationDisorders of Cell Growth & Neoplasia
General Pathology VPM 152 Disorders of Cell Growth & Neoplasia Lecture 3 Rate of growth, local invasion, and metastasis. Molecular basis of cancer (normal cell-cycle and cellular proliferation). Enrique
More informationAdjuvant therapy for thyroid cancer
Carcinoma of the thyroid Adjuvant therapy for thyroid cancer John Hay Department of Radiation Oncology Vancouver Cancer Centre Department of Surgery UBC 1% of all new malignancies 0.5% in men 1.5% in women
More informationCell Communication. Chapter 11. PowerPoint Lectures for Biology, Seventh Edition. Lectures by Chris Romero. Neil Campbell and Jane Reece
Chapter 11 Cell Communication PowerPoint Lectures for Biology, Seventh Edition Neil Campbell and Jane Reece Lectures by Chris Romero Overview: The Cellular Internet Cell-to-cell communication Is absolutely
More informationProblem Set 8 Key 1 of 8
7.06 2003 Problem Set 8 Key 1 of 8 7.06 2003 Problem Set 8 Key 1. As a bright MD/PhD, you are interested in questions about the control of cell number in the body. Recently, you've seen three patients
More informationChapter 20. Cell - Cell Signaling: Hormones and Receptors. Three general types of extracellular signaling. endocrine signaling. paracrine signaling
Chapter 20 Cell - Cell Signaling: Hormones and Receptors Three general types of extracellular signaling endocrine signaling paracrine signaling autocrine signaling Endocrine Signaling - signaling molecules
More informationMembrane associated receptor transfers the information. Second messengers relay information
Membrane associated receptor transfers the information Most signals are polar and large Few of the signals are nonpolar Receptors are intrinsic membrane proteins Extracellular and intracellular domains
More informationDiabetes Mellitus and Breast Cancer
Masur K, Thévenod F, Zänker KS (eds): Diabetes and Cancer. Epidemiological Evidence and Molecular Links. Front Diabetes. Basel, Karger, 2008, vol 19, pp 97 113 Diabetes Mellitus and Breast Cancer Ido Wolf
More informationChapter 9. Cellular Signaling
Chapter 9 Cellular Signaling Cellular Messaging Page 215 Cells can signal to each other and interpret the signals they receive from other cells and the environment Signals are most often chemicals The
More informationBIOL212 Biochemistry of Disease. Metabolic Disorders - Obesity
BIOL212 Biochemistry of Disease Metabolic Disorders - Obesity Obesity Approx. 23% of adults are obese in the U.K. The number of obese children has tripled in 20 years. 10% of six year olds are obese, rising
More informationNeoplasia part I. Dr. Mohsen Dashti. Clinical Medicine & Pathology nd Lecture
Neoplasia part I By Dr. Mohsen Dashti Clinical Medicine & Pathology 316 2 nd Lecture Lecture outline Review of structure & function. Basic definitions. Classification of neoplasms. Morphologic features.
More informationB. Environmental Factors. a. The major risk factor to papillary thyroid cancer is exposure to ionizing radiation, during the first 2 decades of life.
B. Environmental Factors. a. The major risk factor to papillary thyroid cancer is exposure to ionizing radiation, during the first 2 decades of life. b. Deficiency of dietary iodine: - Is linked with a
More informationCancer genetics
Cancer genetics General information about tumorogenesis. Cancer induced by viruses. The role of somatic mutations in cancer production. Oncogenes and Tumor Suppressor Genes (TSG). Hereditary cancer. 1
More information3/29/2012. Thyroid cancer- what s new. Thyroid Cancer. Thyroid cancer is now the most rapidly increasing cancer in women
Thyroid cancer- what s new Thyroid Cancer Changing epidemiology Molecular markers Lymph node dissection Technical advances rhtsh Genetic testing and prophylactic surgery Vandetanib What s new? Jessica
More informationApproach to Thyroid Nodules
Approach to Thyroid Nodules Alice Y.Y. Cheng, MD, FRCPC Twitter: @AliceYYCheng Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted
More informationBiochemistry of Cancer and Tumor Markers
Biochemistry of Cancer and Tumor Markers The term cancer applies to a group of diseases in which cells grow abnormally and form a malignant tumor. It is a long term multistage genetic process. The first
More informationBio 111 Study Guide Chapter 11 Cell Communication
Bio 111 Study Guide Chapter 11 Cell Communication BEFORE CLASS: Reading: Read the introduction on p. 210, and for Concept 11.1, read from the first full paragraph on p. 212. Read all of Concept 11.2. Pay
More informationSection 2 Original Policy Date 2013 Last Review Status/Date September 1, 2014
Policy Number 2.04.82 Molecular Markers in Fine Needle Aspirates of the Thyroid Medical Policy Section 2 Original Policy Date 2013 Last Review Status/Date September 1, 2014 Disclaimer Our medical policies
More informationMolecular Oncology, oncology parameters see each test
Molecular Oncology, oncology parameters see each test DPD deficiency Dihydropyrimidine dehydrogenase deficiency (DPD deficiency) is an autosomal recessive metabolic disorder in which there is absent or
More informationCorporate Medical Policy
Corporate Medical Policy Molecular Analysis for Targeted Therapy for Non-Small Cell Lung File Name: Origination: Last CAP Review: Next CAP Review: Last Review: molecular_analysis_for_targeted_therapy_for_non_small_cell_lung_cancer
More information2015 American Thyroid Association Thyroid Nodule and Cancer Guidelines
2015 American Thyroid Association Thyroid Nodule and Cancer Guidelines Angela M. Leung, MD, MSc, ECNU November 5, 2016 Outline Workup of nontoxic thyroid nodule(s) Ultrasound FNAB Management of FNAB results
More informationEarly Embryonic Development
Early Embryonic Development Maternal effect gene products set the stage by controlling the expression of the first embryonic genes. 1. Transcription factors 2. Receptors 3. Regulatory proteins Maternal
More informationSarah Jaar Marah Al-Darawsheh
22 Sarah Jaar Marah Al-Darawsheh Faisal Mohammad Receptors can be membrane proteins (for water-soluble hormones/ligands) or intracellular (found in the cytosol or nucleus and bind to DNA, for lipid-soluble
More informationKaryotype analysis reveals transloction of chromosome 22 to 9 in CML chronic myelogenous leukemia has fusion protein Bcr-Abl
Chapt. 18 Cancer Molecular Biology of Cancer Student Learning Outcomes: Describe cancer diseases in which cells no longer respond Describe how cancers come from genomic mutations (inherited or somatic)
More informationGeneral Principles of Endocrine Physiology
General Principles of Endocrine Physiology By Dr. Isabel S.S. Hwang Department of Physiology Faculty of Medicine University of Hong Kong The major human endocrine glands Endocrine glands and hormones
More informationNormal thyroid tissue
Thyroid Pathology Overview Normal thyroid tissue Normal thyroid tissue with follicles filled with colloid. Thyroid cells form follicles, spheres of epithelial cells (always single layered in health, usually
More informationCell Communication. Chapter 11. Biology Eighth Edition Neil Campbell and Jane Reece. PowerPoint Lecture Presentations for
Chapter 11 Cell Communication PowerPoint Lecture Presentations for Biology Eighth Edition Neil Campbell and Jane Reece Lectures by Chris Romero, updated by Erin Barley with contributions from Joan Sharp
More informationSignal Transduction Pathways. Part 2
Signal Transduction Pathways Part 2 GPCRs G-protein coupled receptors > 700 GPCRs in humans Mediate responses to senses taste, smell, sight ~ 1000 GPCRs mediate sense of smell in mouse Half of all known
More informationCancer Genetics. What is Cancer? Cancer Classification. Medical Genetics. Uncontrolled growth of cells. Not all tumors are cancerous
Session8 Medical Genetics Cancer Genetics J avad Jamshidi F a s a U n i v e r s i t y o f M e d i c a l S c i e n c e s, N o v e m b e r 2 0 1 7 What is Cancer? Uncontrolled growth of cells Not all tumors
More information